Fluorescein angiographic findings in cases with intermediate uveitis in the inactive phase

Gürlü, Vuslat; Alimgil, Murat Levent; Esgin, Haluk

doi:10.3129/can.j.ophthalmol.06-097

Cited by 5 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…3, 4), as well as providing an indication of large vessel involvement. Optic disk leakage and hyperfluorescence can be assessed in late frames and is often present in chronic macular edema (Pruett et 29 .…”

Section: Fluorescein Angiographymentioning

confidence: 99%

See 1 more Smart Citation

Cystoid Macular Edema in Uveitis

Smet¹,

Okada²

2010

Developments in Ophthalmology

View full text Add to dashboard Cite

Macular edema is a major cause of morbidity in uveitis patients. Inflammatory mediators act on the integrity of the blood ocular barrier and on the function of the RPE pump. Chronicity leads to irreversible changes and is reported to cause up to 30% of permanent visual loss in uveitis patients. Assessing the presence and severity of edema with appropriate investigational techniques (Spectral domain OCT, and angiography) help to determine its reversibility and define a therapeutic strategy wherein intraocular steroids play a key role while RPE pump stimulators and surgery are restricted to more severe disease or the presence of tractional syndromes.

show abstract

Section: Fluorescein Angiographymentioning

confidence: 99%

“…Optic disk hyperfluorescence was present in 66% of patients with quiescent intermediate uveitis of which 24% had macular edema(Gürlü et al, 2007) …”

mentioning

confidence: 98%

Cystoid Macular Edema in Uveitis

Smet¹,

Okada²

2010

Developments in Ophthalmology

View full text Add to dashboard Cite

show abstract

“…This was shown in a study that used a 50 degree camera and peripheral sweeps. 3 The purpose of this study was to report ultra wide field fluorescein angiographic findings in patients with intermediate uveitis using a 200 degree scanning laser ophthalmoscope (Optos Panoramic P200MA; Optos PLC, Dunfermline, Scotland, United Kingdom. )…”

Section: Introductionmentioning

confidence: 99%

Patterns of Periphlebitis in Intermediate Uveitis using Ultra Wide Field Fluorescein Angiography

Tsui

Kaines

Schwartz

2009

Seminars in Ophthalmology

View full text Add to dashboard Cite

Intermediate uveitis is a collection of diseases which can be caused by sarcoidosis in approximately fifty percent of patients. We performed a retrospective chart review of 6 patients with acquisition and interpretation of ultra wide field fluorescein angiograms. Two eyes had central, large vessel staining; six eyes had peripheral, small vessel staining; and two eyes had both patterns of staining. We conclude that ultra wide field fluorescein angiography is important to detect inflammation early and follow treatment in patients with intermediate uveitis. Future studies with ultra wide field fluorescein angiography may help to diagnose different types of intermediate uveitis and offer insights into the pathogenesis of disease.

show abstract

Review of Intermediate Uveitis

Lai¹,

Liu²,

Lam³

2013

Asia-Pacific Journal of Ophthalmology

View full text Add to dashboard Cite

The purpose of this article is to highlight evidence about the medical and surgical management of intermediate uveitis (IU). Updated understandings of the immunopathology of IU were reviewed in this retrospective literature review. Literature selection for this review was based on the PubMed database (National Library of Medicine) and OVID database (Wolters Kluwer). Articles deemed relevant were selected and highlighted. Intermediate uveitis is most often a benign form of uveitis. Since intermediate uveitis has been described in association with different systemic disorders, the initial diagnostic evaluation should serve to exclude masquerade syndromes and infectious diseases in which immunosuppression may be ineffective or contraindicated. Although the pathogenesis of intermediate uveitis is not fully understood, identification of proinflammatory molecules involved in the IU has contributed to the development and implementation of new therapies. Studies about the use of various immunosuppressants, biological agents and surgical treatment on IU have provided more evidence for managing IU. Nevertheless, corticosteroids remain the mainstay of treatment. The treatment options of intermediate uveitis are evolving, with the development of various immunosuppressants and biological agents. The management of intermediate uveitis should be tailored individually, based on specific causes of the disease and associated complications.

show abstract

Fluorescein angiographic findings in cases with intermediate uveitis in the inactive phase

Cited by 5 publications

References 9 publications

Cystoid Macular Edema in Uveitis

Cystoid Macular Edema in Uveitis

Patterns of Periphlebitis in Intermediate Uveitis using Ultra Wide Field Fluorescein Angiography

Review of Intermediate Uveitis

Contact Info

Product

Resources

About